Scholarly Index
Angeles Alvarez Secord
Duke Medical Center; 45,929 total citations; 480 total publications; best world rank #82
Duke Medical Center
45,929Total citations
480Total publications
71H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ovarian cancer diagnosis and treatment | Lifetime | 112 | US 65 | 99.37 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 105 | US 57 | 99.32 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 121 | US 56 | 98.24 |
| PARP inhibition in cancer therapy | Lifetime | 141 | US 66 | 97.92 |
| Uterine Myomas and Treatments | Lifetime | 545 | US 185 | 96.70 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 82 | US 21 | 98.59 |
| PARP inhibition in cancer therapy | 2021-2025 | 108 | US 46 | 95.97 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 183 | US 45 | 96.86 |
| Intraperitoneal and Appendiceal Malignancies | 2021-2025 | 910 | US 218 | 71.04 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 833 | US 276 | 61.96 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 854 | US 120 | 57.92 |
| Intestinal and Peritoneal Adhesions | 2021-2025 | 923 | US 161 | 48.83 |